Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Genes, coagulation and cardiovascular risk.

M B Donati1, F Zito, A D Castelnuovo

  • 1Angela Valenti Laboratory of Genetic and Environmental Risk Factors for Thrombotic Disease, Department of Vascular Medicine and Pharmacology, Istituto di Ricerche Farmacologiche Mario Negri, Consorzio Mario Negri Sud, Santa Maria Imbaro, Italy.

Journal of Human Hypertension
|July 6, 2000
PubMed
Summary

Genetic variations in coagulation factor VII (FVII) influence coronary artery disease (CAD) risk. Specific FVII gene polymorphisms offer protection against myocardial infarction, impacting disease rates across Europe.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Dysphagia in hospitalized older patients: the Report-AGE project.

European geriatric medicine·2026
Same author

Anti-SARS-CoV-2 antibody levels and kinetics of vaccine response: potential role for unresolved inflammation following recovery from SARS-CoV-2 infection.

Scientific reports·2022
Same author

Consumption of ultra-processed foods and health status: a systematic review and meta-analysis.

The British journal of nutrition·2020
Same author

Lifestyle and biological factors influence the relationship between mental health and low-grade inflammation.

Brain, behavior, and immunity·2019
Same author

Impact of combined healthy lifestyle factors on survival in an adult general population and in high-risk groups: prospective results from the Moli-sani Study.

Journal of internal medicine·2019
Same author

Consumption of whole grain food and its determinants in a general Italian population: Results from the INHES study.

Nutrition, metabolism, and cardiovascular diseases : NMCD·2019

Area of Science:

  • Cardiovascular Genetics
  • Hemostasis and Thrombosis

Background:

  • Coronary artery disease (CAD) is multifactorial, involving genetic and environmental factors.
  • Coagulation activation is crucial in thrombus formation, with factor variations linked to CAD risk.
  • Genetic polymorphisms in coagulation factor genes contribute to disease development.

Purpose of the Study:

  • Investigate the association between coagulation factor VII (FVII) gene polymorphisms and the risk of familial myocardial infarction.
  • Examine the geographical distribution of these polymorphisms in relation to myocardial infarction mortality rates.
  • Explore how these polymorphisms influence FVII levels and their response to environmental factors.

Main Methods:

  • Analysis of three polymorphic alleles in the coagulation factor VII (FVII) gene.

Related Experiment Videos

  • Correlation of allele distribution with myocardial infarction mortality rates across European populations.
  • Assessment of FVII modulation by environmental factors like triglycerides and smoking.
  • Investigation of gender-dependent regulation of FVII levels.

    • Main Results:

    • Three FVII gene polymorphisms are associated with a protective effect against familial myocardial infarction.
    • The prevalence of these protective polymorphisms inversely correlates with myocardial infarction mortality across Europe.
    • These polymorphisms are key determinants of human FVII variability and modulate FVII response to environmental factors.
    • A gender-dependent regulation of FVII, possibly linked to sex hormones, was observed.

    Conclusions:

    • FVII gene polymorphisms play a significant role in determining CAD risk and myocardial infarction incidence.
    • Understanding these genetic factors can inform population-level risk assessment and prevention strategies.
    • Therapeutic strategies, such as lowering FVII levels with warfarin, may mimic the protective effects of favorable genotypes.